COVID-19 convalescent plasma; time for "goal directed therapy"?
作者信息
Knudson Charles Michael, Jackson J Brooks
机构信息
DeGowin Blood Center, Department of Pathology, University of Iowa Hospitals & Clinics (UIHC), Iowa City, Iowa, USA.
出版信息
Transfusion. 2021 May;61(5):1654-1656. doi: 10.1111/trf.16381. Epub 2021 Mar 26.
Abstract
摘要
相似文献
1
COVID-19 convalescent plasma; time for "goal directed therapy"?新冠康复者血浆；是时候采用“目标导向治疗”了吗？
Transfusion. 2021 May;61(5):1654-1656. doi: 10.1111/trf.16381. Epub 2021 Mar 26.
2
Convalescent plasma for COVID-19 considerations.关于新冠病毒病恢复期血浆的考量
Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.
3
Covid-19 convalescent plasma and SARS-CoV-2 viral variants.新冠康复者血浆与严重急性呼吸综合征冠状病毒2病毒变体
Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.
4
[Convalescent plasma therapy in COVID-19 patients].[新冠病毒肺炎患者的恢复期血浆治疗]
Medicina (B Aires). 2021;81(2):306.
5
COVID-19 convalescent plasma therapy and immunodeficiency.新冠康复者血浆疗法与免疫缺陷
Transfus Clin Biol. 2021 Aug;28(3):306-307. doi: 10.1016/j.tracli.2021.05.007. Epub 2021 May 29.
6
Use of Convalescent Plasma in the Management of COVID-19.康复期血浆在新型冠状病毒肺炎治疗中的应用
Mo Med. 2021 Mar-Apr;118(2):118.
7
Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.2019年冠状病毒病（COVID-19）抗体动力学对免疫及恢复期血浆治疗的影响
Clin Infect Dis. 2021 Aug 2;73(3):e540-e542. doi: 10.1093/cid/ciaa1213.
8
Correspondence on 'CONVALESCENT plasma for COVID-19'.关于“COVID-19康复期血浆治疗”的通信
Eur J Clin Invest. 2021 Nov;51(11):e13677. doi: 10.1111/eci.13677. Epub 2021 Sep 13.
9
How Safe Is COVID-19 Convalescent Plasma?新冠康复者血浆有多安全？
Mayo Clin Proc. 2021 Aug;96(8):2279-2281. doi: 10.1016/j.mayocp.2021.06.011. Epub 2021 Jun 25.
10
[COVID-19: blood sufficiency versus convalescent plasma?].[新冠病毒肺炎：血液充足疗法与康复期血浆疗法？]
Rev Med Chil. 2020 Jun;148(6):721-723. doi: 10.4067/S0034-98872020000600721.
引用本文的文献
1
SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors.接受来自正常和接种疫苗供体的新冠康复期血浆的新冠肺炎患者体内的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体变化
Transfus Apher Sci. 2022 Apr;61(2):103326. doi: 10.1016/j.transci.2021.103326. Epub 2021 Nov 23.
本文引用的文献
1
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.恢复期血浆抗体水平与新冠死亡风险。
N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.
2
Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma.时间序列分析揭示了新型冠状病毒疾病恢复期血浆中和能力的下降，并证明了修订的资格标准是合理的。
J Infect Dis. 2021 Mar 3;223(5):743-751. doi: 10.1093/infdis/jiaa803.
3
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.早期高滴度血浆疗法预防老年人重症 COVID-19。
N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6.
4
Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis.COVID-19 重症和危重症患者恢复期血浆治疗的安全性和有效性：系统评价和荟萃分析。
Aging (Albany NY). 2020 Dec 15;13(1):1498-1509. doi: 10.18632/aging.202195.
5
Effectiveness of Convalescent Plasma Therapy in the Treatment of Moderate to Severe COVID 19 Patients: A Systematic Review and Meta-Analysis.康复期血浆疗法治疗中重度新型冠状病毒肺炎患者的有效性：一项系统评价与Meta分析
J Assoc Physicians India. 2020 Dec;68(12):35-43.
6
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.新冠肺炎重症肺炎患者恢复期血浆的随机临床试验。
N Engl J Med. 2021 Feb 18;384(7):619-629. doi: 10.1056/NEJMoa2031304. Epub 2020 Nov 24.
7
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.
8
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.冠状病毒抗体介导免疫的系统评价：动力学、保护相关性及与严重程度的关系。
Nat Commun. 2020 Sep 17;11(1):4704. doi: 10.1038/s41467-020-18450-4.
9
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.血清学检测评估康复的新冠肺炎患者中高度可变的新冠病毒中和抗体活性。
J Clin Microbiol. 2020 Nov 18;58(12). doi: 10.1128/JCM.02005-20.
10
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.性别、年龄和住院情况会影响 COVID-19 恢复期血浆捐献者人群的抗体反应。
J Clin Invest. 2020 Nov 2;130(11):6141-6150. doi: 10.1172/JCI142004.
Zotero 插件